LES LABORATOIRES SERVIER

In News

Arbitration ruling partially terminates Cellectis-Servier license agreement - Investing.com

Investing.com - Dec 15, 2025

Cellectis Announces Arbitral Decision in Dispute with Servier - GlobeNewswire

GlobeNewswire - Dec 15, 2025

Cellectis announces arbitral decision in dispute with Servier - TipRanks

TipRanks - Dec 15, 2025

White & Case wins “Impact Case of the Year” award at 2025 LMG Life Sciences EMEA Awards - White & Case

White & Case - Jun 12, 2025

HappyTrainees® Ranking: Servier in second position! - Servier

Servier - Nov 21, 2025

France’s Servier Acquires Potential Fragile X Drug in $450 Million Deal - Bloomberg.com

Bloomberg.com - Sep 07, 2025

Servier Buys Fragile X Syndrome Candidate for up to $450M - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Sep 08, 2025

Servier reaches settlement with EU over interest on antitrust fine - MLex

MLex - May 15, 2025

Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide - PR Newswire

PR Newswire - Sep 02, 2025

BC Partners to Acquire Servier’s Generic Drug Unit Biogaran - Bloomberg.com

Bloomberg.com - Jul 30, 2025

Servier supercharges neuro pipeline with $450M deal for Fragile X syndrome candidate - Fierce Biotech

Fierce Biotech - Sep 08, 2025

BC Partners Bids For Biogaran Buyout – But Will It Face French Pushback? - Citeline News & Insights

Citeline News & Insights - Jul 31, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment